Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells
Mauricio P. Pinto 3, Paula Sotomayor, Gonzalo Carrasco-Avino, Alejandro H. Corvalan and Gareth I. Owen
Evolutionary history of the reprimo tumor suppressor gene family in vertebrates with a description of a new reprimo gene lineage
Wichmann1, Zavala K, Hoffmann FG, Vandewege ,0MW, Corvalán AH, Amigo JD2, Owen GI, Opazo JC2
Venlafaxine treatment after endothelian-1-induced cortical stroke modulates growth factor expression and reduces tissue damage in rats
Zepeda R1, Contreras V, Pissani C, Stack K, Vargas M, Owen GI, Lazo OM2, Bronfman FC2.
Study protocol for the Maule Cohort (MAUCO) of chronic diseases, Chile 2014-2024
Catterina Ferreccio3, Juan Carlos Roa, Claudia Bambs, Alejandra Vives, Alejandro H. Corvalán, Sandra Cortés, Claudia Foerster, Johanna Acevedo, Andrea Huidobro, Alvaro Passi, Pablo Toro, Yerko Covacevich, Rolando de la Cruz, Jill Koshiol, Mauricio Olivares, Juan Francisco Miquel, Francisco Cruz, Raúl Silva, Andrew F. Quest, Marcelo J. Kogan, Pablo F. Castro and Sergio Lavandero
The case for aflatoxins in the causal chain of gallbladder cancer
Claudia Foerster1, Jill Koshiolc, Ariel R. Guerrero, Marcelo J. Kogan, Catterina Ferreccio2
Gastric Cancer: Nanoparticles as Tools to Improve Treatment Efficacy
Ariel R. Guerrero1, Felipe Oyarzun-Ampuero, Natalia Hassan, Alejandro H. Corvalán, Andrew F.G. Quest and Marcelo J. Kogan
